PD-L1: an unavoidable biomarker in advanced triple-negative breast cancer

被引：9
|
作者：
Akiki, Mira [1 ]
Haddad, Fady Gh [2 ]
Kourie, Hampig Raphael [2 ]
Khaddage, Abir [1 ]
Smayra, Viviane Track [1 ]
机构：
[1] St Joseph Univ, Fac Med, Pathol Dept, Beirut, Lebanon
[2] St Joseph Univ, Fac Med, Hematol & Oncol Dept, Beirut, Lebanon
来源：
BIOMARKERS IN MEDICINE | 2019年 / 13卷 / 18期
关键词：
breast cancer; clinical trials; immunotherapy; oncology; PD-L1; TNBC; triple negative; EXPRESSION;
D O I：
10.2217/bmm-2019-0344
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：1539 / 1541
页数：3
相关论文
共 50 条
  • [1] PD-L1 Expression in Triple-Negative Breast Cancer
    Mittendorf, Elizabeth A.
    Philips, Anne V.
    Meric-Bernstam, Funda
    Qiao, Na
    Wu, Yun
    Harrington, Susan
    Su, Xiaoping
    Wang, Ying
    Gonzalez-Angulo, Ana M.
    Akcakanat, Argun
    Chawla, Akhil
    Curran, Michael
    Hwu, Patrick
    Sharma, Padmanee
    Litton, Jennifer K.
    Molldrem, Jeffrey J.
    Alatrash, Gheath
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (04) : 361 - 370
  • [2] The risk of PD-L1 expression misclassification in triple-negative breast cancer
    Ben Dori, Shani
    Aizic, Asaf
    Zubkov, Asia
    Tsuriel, Shlomo
    Sabo, Edmond
    Hershkovitz, Dov
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (02) : 297 - 305
  • [3] The risk of PD-L1 expression misclassification in triple-negative breast cancer
    Shani Ben Dori
    Asaf Aizic
    Asia Zubkov
    Shlomo Tsuriel
    Edmond Sabo
    Dov Hershkovitz
    Breast Cancer Research and Treatment, 2022, 194 : 297 - 305
  • [4] Expression of PD-L1 and NY-ESO-1 in early and advanced triple-negative breast cancer
    Tessari, Anna
    Paolini, Biagio
    Mariani, Luigi
    Pilla, Lorenzo
    Carcangiu, Maria Luisa
    Moliterni, Angela
    De Braud, Filippo G.
    Cresta, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Effects of Cardamonin on PD-1/PD-L1 Checkpoint in Triple-Negative Breast Cancer
    Mendonca, Patricia
    Hill, Lonnie
    Soliman, Karam F. A.
    FASEB JOURNAL, 2022, 36
  • [6] PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression
    Alkaabi, Duaa
    Arafat, Kholoud
    Sulaiman, Shahrazad
    Al-Azawi, Aya Mudhafar
    Attoub, Samir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [7] PD-L1 Gene Amplification in Triple-negative Breast Cancer: Implications for Immunotherapy
    Peng, K. X.
    Anderson, K. S.
    McCullough, A. E.
    Reddy, S. K.
    Basu, G. D.
    Northfelt, D. W.
    Andreozzi, M.
    Barrett, M. T.
    Pockaj, B. A.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S70 - S70
  • [8] Role of PD-L1 expression in triple-negative breast cancer stem cells
    Di Nicola, Massimo A.
    Castagnoli, Lorenzo
    Cancila, Valeria
    Romero, Sandra
    Faraci, Simona
    Chiodoni, Claudia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
    Li, Chia-Wei
    Lim, Seung-Oe
    Chung, Ezra M.
    Kim, Yong-Soo
    Park, Andrew H.
    Yao, Jun
    Cha, Jong-Ho
    Xia, Weiya
    Chan, Li-Chuan
    Kim, Taewan
    Chang, Shih-Shin
    Lee, Heng-Huan
    Chou, Chao-Kai
    Liu, Yen-Liang
    Yeh, Hsin-Chih
    Perillo, Evan P.
    Dunn, Andrew K.
    Kuo, Chu-Wei
    Khoo, Kay-Hooi
    Hsu, Jennifer L.
    Wu, Yun
    Hsu, Jung-Mao
    Yamaguchi, Hirohito
    Huang, Tzu-Hsuan
    Sahin, Aysegul A.
    Hortobagyi, Gabriel N.
    Yoo, Stephen S.
    Hung, Mien-Chie
    CANCER CELL, 2018, 33 (02) : 187 - +
  • [10] Eradication of triple-negative breast cancer cells by targeting glycosylated PD-L1
    Lim, Seung-Oe
    Li, Chia-Wei
    Hung, Mien-Chie
    CANCER RESEARCH, 2018, 78 (13)
12345